This invention discloses a
dapagliflozin tablet, comprising a tablet core. The tablet core is made by compressing a mixture of
drug-containing granules and additional components. By weight, the
drug-containing granules are prepared by premixing, sieving, and dry
granulation of 12.30 parts
dapagliflozin, 50.00 parts
anhydrous lactose, 87.50 parts
microcrystalline cellulose, 2.50 parts crospovidone, and 2.50 parts silica. The additional components consist of 84.00 parts
microcrystalline cellulose, 7.50 parts crospovidone, 1.25 parts silica, and 2.50 parts
magnesium stearate. After mixing the
drug-containing granules with the
microcrystalline cellulose, crospovidone, and silica in the additional components,
magnesium stearate is added and mixed. Through the internal and external segmented ratio of
microcrystalline cellulose, crospovidone, and silica, combined with premixing, sieving, and suitable dry
granulation conditions, the dispersion state of the low proportion of active pharmaceutical ingredient and the subsequent material flowability are improved. This has the advantages of improving tablet quality consistency and suitability for industrial production.